Exenatide — Drug Intelligence | 6 EU Trials

Filter these 6 trials by condition, phase, country and more.

6 Registered trials

1 Recruiting

2 Completed trials

4 Sponsors

6 Countries

Phase II

Phase I/II

Phase II: 5 Phase I/II: 1

Sponsors using this IMP

6 total

An Open-label Phase 2b Study with Blinded Evaluation of the Combination of Amodiaquine and Potassium Canrenoate with Exenatide or Glibenclam… Not authorised

2025-522796-28-00 Phase II 1 country Genesis Pharma S.A.
Image-Verapamil SR in Adults with Type 1 Diabetes (Image-VER-A-T1D) Pending

2024-518554-17-00 Phase II 2 countries Radboud universitair medisch centrum Stichting
Imaging beta cells after gestational diabetes Pending

2024-520392-27-00 Phase II 1 country Radboud universitair medisch centrum Stichting
Testing Exendin PET, a new imaging technique, for imaging paragangliomas Recruiting

2024-516755-40-00 Phase II 1 country Stichting Radboud universitair medisch centrum
Identification and clinical relevance of an oxytocin-deficient state: randomized, crossover, placebo-controlled pilot physiopathological stu… Ended

2024-515588-67-00 Phase I/II 1 country Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Effect of Exenatide on disease progression in early Parkinson’s disease. Ended

2024-520069-30-00 Phase II 1 country Region Stockholm – SLSO

Showing 1–6 of 6 trials